The role of blood-brain barrier permeability in brain tumor imaging and therapeutics

American Journal of Roentgenology

Volumn 185, Issue 3, 2005, Pages 763-767

  Provenzale, James M ^a   Mukundan, Srinivasan ^a   Dewhirst, Mark ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ANGIOGENESIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CONTRAST ENHANCEMENT; DRUG BLOOD LEVEL; HUMAN; MEMBRANE PERMEABILITY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ANIMAL; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; PERMEABILITY;

EID: 27744607174     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.185.3.01850763     Document Type: Article

References (29)

1. Bart J, Groen HJM, Hendrikse NH, van der Graaf WTA, Vaalburg W, de Vries EGE. The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Res 2000; 26:449-462
2. Neuwelt EA. Mechanisms of disease: the blood-brain barrier. Neurosurgery 2004; 54:131-142
3. Pardridge WM. Introduction to the blood-brain barrier: methodology, biology and pathology. Cambridge: Cambridge University Press, 1998
4. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182-1186
5. Puduvalli VK, Sawaya R. Antiangiogenesis: therapeutic strategies and clinical implications for brain tumors. J Neurooncol 2000; 50:189-200
6. Dewhirst MW, Shan S, Cao Y, Moeller B, Yuan F. Li C. Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals. Dis Markers 2002; 18:293-311
7. Machein MR, Kullmer J, Fietach BL, Plate KH. Warnke PC. Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 1999; 44:732-740
8. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A 1996; 93:14765-14770
9. Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004; 10:145-147
10. Pham CD, Roberts TP, van Bruggen N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 1998; 16:225-230
11. Brasch RC, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997; 7:68-74
12. Gossmann A, Helbich TH, Kuriyama N, et al. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 2002; 15:233-240
13. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003; 17:509-520
14. Roberts HC, Roberts TPL, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am J Neuroradiol 2000; 21:891-899
15. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7:91-101
16. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10:223-232
17. Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003; 76:39-50
18. Yang S, Law M, Zagzag D, et al. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. Am J Neuroradiol 2003; 24:1554-1559
19. Harroon HA, Buckley DL, Pantaker TA, et al. A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. J Magn Reson Imaging 2004; 19:527-536
20. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271:58-65
21. Siegal T, Zylber-Katz E. Strategies for increasing drug delivery to the brain: focus on brain lymphoma. Clin Pharmacokinet 2002; 41:171-186
22. Bartus RT. The blood-brain barrier as a target for pharmacological modulation. Curr Opin Drug Discov Devel 1999; 2:152-167
23. Uchegbu IF. Parenteral drug delivery: 1. Pharmaceutical J 1999; 263:309-318
24. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 1994; 54:3352-3356
25. Yuan F, Dellian M, Fukumura D, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995; 55:3752-3756
26. Wu N, Da D, Rudoll T, Needham D, Whorton A, Dewhirst M. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res 1993; 53:3765-3770
27. Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61:3027-3032
28. Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000; 60:6950-6957
29. Radiology Department, Duke University Medical Center Web site. www.radweb.mc.duke.edu/db-plab/. Accessed February 10, 2005